Patents by Inventor Niels C. Riedemann

Niels C. Riedemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of inflammatory diseases with inhibitors of C5A activity
    Patent number: 11890349
    Abstract: The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: February 6, 2024
    Assignee: InflaRx GmbH
    Inventors: Renfeng Guo, Niels C. Riedemann
  • HUMANIZED ANTI-C5A ANTIBODIES
    Publication number: 20230279087
    Abstract: The present invention relates to antibodies that specifically bind to a conformational epitope of human C5a. The invention particularly relates to humanized anti-C5a antibodies. The antibodies described herein are useful as active agents in pharmaceutical compositions. The antibodies and pharmaceutical compositions are especially useful for the treatment and prevention of diseases or disorders involving pathological C5a activity.
    Type: Application
    Filed: May 6, 2021
    Publication date: September 7, 2023
    Applicant: InflaRx GmbH
    Inventors: Renfeng GUO, Niels C. RIEDEMANN
  • Inhibitors of C5a for the Treatment of Corona Virus Infection
    Publication number: 20230158060
    Abstract: The present invention relates to an inhibitor of C5a activity medical condition caused by or associated with infection with a corona virus. The invention also relates to the use of an inhibitor of C5a activity in the reduction of an inflammatory response in a subject suffering from a corona virus infection. The invention further relates to an inhibitor of C5a activity for use in the improvement of organ function, in particular lung function and/or hepatic function, in a subject suffering from a corona virus infection.
    Type: Application
    Filed: March 27, 2020
    Publication date: May 25, 2023
    Applicant: InflaRx GmbH
    Inventors: Niels C. RIEDEMANN, Renfeng GUO
  • Treatment of inflammatory diseases with inhibitors of C5A activity
    Patent number: 11464868
    Abstract: The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
    Type: Grant
    Filed: August 7, 2019
    Date of Patent: October 11, 2022
    Assignee: InflaRx GmbH
    Inventors: Renfeng Guo, Niels C. Riedemann
  • TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY
    Publication number: 20210046191
    Abstract: The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
    Type: Application
    Filed: November 2, 2020
    Publication date: February 18, 2021
    Applicant: InflaRx GmbH
    Inventors: Renfeng Guo, Niels C. Riedemann
  • TREATMENT OF INFLAMMATORY DISEASES WITH INHIBITORS OF C5A ACTIVITY
    Publication number: 20200061202
    Abstract: The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
    Type: Application
    Filed: August 7, 2019
    Publication date: February 27, 2020
    Applicant: InflaRx GmbH
    Inventors: Renfeng Guo, Niels C. Riedemann
  • Treatment of inflammatory diseases with inhibitors of C5a activity
    Patent number: 10376595
    Abstract: The present invention relates to inhibitors of C5a activity and their use in the treatment of cutaneous, neutrophilic, inflammatory diseases in a subject.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: August 13, 2019
    Assignee: InflaRx GmbH
    Inventors: Renfeng Guo, Niels C. Riedemann
  • Compositions and methods for the diagnosis and treatment of sepsis
    Patent number: 7455837
    Abstract: The present invention relates to methods and compositions for the diagnosis and treatment of sepsis. The present invention also provides methods of providing a prognosis to a patient with sepsis. In particular, the present invention relates to compositions and methods for the detection of C5aR expression and the correlation of C5aR expression level with prognosis in sepsis.
    Type: Grant
    Filed: November 5, 2003
    Date of Patent: November 25, 2008
    Assignee: The Regents of the University of Michigan
    Inventors: Renfeng Guo, Niels C. Riedemann, Peter A. Ward, Markus Huber-Lang, J. Vidya Sarma
  • Compositions and methods for the diagnosis and treatment of sepsis
    Publication number: 20040166541
    Abstract: The present invention relates to methods and compositions for the diagnosis and treatment of sepsis. The present invention also provides methods of providing a prognosis to a patient with sepsis. In particular, the present invention relates to compositions and methods for the detection of C5aR expression and the correlation of C5aR expression level with prognosis in sepsis.
    Type: Application
    Filed: November 5, 2003
    Publication date: August 26, 2004
    Applicant: The Regents of the University of Michigan
    Inventors: Renfeng Guo, Niels C. Riedemann, Peter A. Ward, Markus Huber-Lang, J. Vidya Sarma